Related Experiment Video

Updated: Mar 15, 2026

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro
08:04

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Published on: March 18, 2014

13.4K

Progress and opportunities for immune therapeutics in osteosarcoma

Christina K Lettieri1, Nicole Appel2, Nicole Labban2

  • 1Children's Hospital & Medical Center, Omaha, NE 68198, USA.

Immunotherapy
|September 9, 2016
PubMed

Insights

Osteosarcoma survival rates remain stagnant, with limited options for relapsed patients. This review explores promising immune therapies, including checkpoint blockade, for treating this challenging bone cancer.

Area of Science:

  • Oncology
  • Immunology
  • Bone Cancer Research

Background:

  • Survival outcomes for osteosarcoma have not improved since the 1980s.
  • Patients with relapsed or refractory osteosarcoma face limited treatment options and poor prognoses.
  • Traditional immunotherapies like tumor vaccines and monoclonal antibodies have shown minimal efficacy in solid tumors.

Purpose of the Study:

  • To review existing data on the use of immune therapies in osteosarcoma.
  • To summarize the progress of immunotherapeutic strategies in osteosarcoma treatment.
  • To highlight the potential of novel immune checkpoint blockade strategies.

Main Methods:

  • Literature review of existing data on immunotherapies in osteosarcoma.
  • Analysis of the efficacy of various immune-based treatments.
  • Summary of recent advancements in immune checkpoint blockade for solid tumors.

Main Results:

  • Immune therapies, particularly immune checkpoint blockade, show potential in revitalizing osteosarcoma treatment.
  • Novel strategies offer hope for patients with relapsed or refractory disease.
  • Further research is needed to fully elucidate the role of immunotherapy in osteosarcoma.

Conclusions:

  • Immune therapies represent a promising frontier for improving osteosarcoma outcomes.
  • Immune checkpoint blockade strategies are gaining traction for solid tumors, including osteosarcoma.
  • This review synthesizes current evidence and future directions for immunotherapy in osteosarcoma.
Keywords:
clinical trialsimmune checkpoint inhibitorsimmune toleranceimmunotherapyosteosarcoma

More Related Videos

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

7.7K
Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

11.9K

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.7K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K